Immunity to Schistosoma mansoni in guinea-pigs vaccinated with radiation-attenuated cercariae. T-cell activation of macrophages for larval killing
- PMID: 2832308
- PMCID: PMC1454522
Immunity to Schistosoma mansoni in guinea-pigs vaccinated with radiation-attenuated cercariae. T-cell activation of macrophages for larval killing
Abstract
This study addresses macrophage activation in guinea-pigs vaccinated with radiation-attenuated cercariae of Schistosoma mansoni. Peritoneal exudate macrophages elicited in vaccinated animals by mineral oil injection were activated to kill larval schistosomes in vitro. Killing efficiency is dependent upon the cell: target ratio employed and is enhanced by, but is not strictly dependent on, the presence of specific antibodies. Macrophages co-cultured with parasites release superoxide radicals and hydrogen peroxide, but the use of inhibitors has shown that neither of these reactive oxygen intermediates are the causal agents of cellular cytotoxicity in this system. Oil-elicited macrophages from naive guinea-pigs do not show comparable activation; they can, however, be activated in vitro by incubation with culture supernatant fluids from schistosome antigen-stimulated spleen, or lymph node cells harvested from vaccinated guinea-pigs. Naive macrophages activated in this way kill schistosomula in vitro and release the activation markers IL-1 and superoxide anion. The macrophage-activating factor (MAF) present in spleen cell culture supernatant fluids has a MW of 35,000-55,000, but does not have the chemical characteristics of gamma-interferon. In this study MAF is shown to be released by a population of lymph node cells that does not adhere to nylon-wool columns, that responds well in proliferation assays to schistosome antigens and to the T-cell mitogen concanavalin A, but does not respond to the B-cell mitogen lipopolysaccharide. These cells have been identified as small lymphocytes.
Similar articles
-
Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.J Immunol. 1983 Sep;131(3):1481-6. J Immunol. 1983. PMID: 6350456
-
Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.J Immunol. 1984 Sep;133(3):1587-93. J Immunol. 1984. PMID: 6431002
-
T cell clones for antigen selection and lymphokine production in murine Schistosomiasis mansoni.J Immunol. 1990 Apr 1;144(7):2757-62. J Immunol. 1990. PMID: 1690777
-
T cell derived cytokines in lung-phase immunity to Schistosoma mansoni.Mem Inst Oswaldo Cruz. 1992;87 Suppl 4:105-9. doi: 10.1590/s0074-02761992000800015. Mem Inst Oswaldo Cruz. 1992. PMID: 1343880 Review.
-
Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?Parasit Vectors. 2016 Feb 17;9:89. doi: 10.1186/s13071-016-1369-9. Parasit Vectors. 2016. PMID: 26888413 Free PMC article. Review.
Cited by
-
Murine T-cell clones against Entamoeba histolytica: in vivo and in vitro characterization.Immunology. 1989 Jan;66(1):76-82. Immunology. 1989. PMID: 15493266 Free PMC article.
-
Application of microphysiological systems to unravel the mechanisms of schistosomiasis egg extravasation.Front Cell Infect Microbiol. 2025 Feb 18;15:1521265. doi: 10.3389/fcimb.2025.1521265. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40041145 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources